Reinhild Klein Selected Research

Antineutrophil Cytoplasmic Antibodies (ANCA)

1/2013

Cholestatic liver disease after rituximab and adalimumab and the possible role of cross-reacting antibodies to Fab 2 fragments.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reinhild Klein Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 09/2010
9	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 04/2002
6	COVID-19 01/2022 - 11/2020
6	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 07/2012
5	Liver Diseases (Liver Disease) 01/2013 - 04/2002
4	Infections 01/2022 - 01/2003
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 12/2002
3	Autoimmune Hepatitis 07/2012 - 07/2009
3	Fibromyalgia (Fibrositis) 10/2007 - 02/2002
2	Sclerosing Cholangitis 01/2022 - 05/2018
2	Inflammation (Inflammations) 01/2022 - 02/2012
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 07/2020
2	Rheumatoid Arthritis 11/2020 - 11/2003
2	Thyroiditis 05/2012 - 09/2009
2	Uveitis 02/2012 - 05/2007
2	Connective Tissue Diseases (Connective Tissue Disease) 02/2012 - 09/2007
2	Multiple Sclerosis 02/2011 - 11/2003
2	Hypersensitivity (Allergy) 12/2009 - 10/2007
2	Chronic Hepatitis C 05/2009 - 01/2003
2	Eosinophilia 01/2006 - 12/2002
1	Familial Mediterranean Fever (Periodic Disease) 02/2021
1	Cryopyrin-Associated Periodic Syndromes 02/2021
1	digital ulcers 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Common Cold 01/2021
1	COVID-19 related pediatric multisystem inflammatory disease 11/2020
1	Thrombosis (Thrombus) 11/2020
1	Granuloma 11/2019
1	Testicular Neoplasms (Testicular Cancer) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Leukemia 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Color Vision Defects (Color Blindness) 12/2017
1	Bronchiolitis Obliterans Syndrome 08/2015
1	Jaundice (Icterus) 01/2014
1	Thymoma (Thymic Carcinoma) 09/2013
1	Myasthenia Gravis 09/2013
1	Hepatitis A (Hepatitis, Infectious) 01/2013
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2013
1	Pulmonary Hypertension 07/2012
1	Pulmonary Arterial Hypertension 07/2012

Drug/Important Bio-Agent (IBA)

19	AntibodiesIBA 01/2022 - 02/2002
9	Peptides (Polypeptides)IBA 01/2022 - 02/2010
8	AutoantibodiesIBA 09/2013 - 11/2003
6	AntigensIBA 07/2020 - 05/2007
5	AutoantigensIBA 05/2018 - 06/2005
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2022 - 07/2012
4	EpitopesIBA 01/2021 - 02/2010
3	HLA-DR Antigens (HLA-DR)IBA 01/2021 - 07/2012
3	EnzymesIBA 07/2012 - 09/2002
3	Proteins (Proteins, Gene)FDA Link 02/2012 - 02/2011
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2022 - 01/2020
2	VaccinesIBA 01/2022 - 01/2021
2	Protein Subunit VaccinesIBA 01/2022 - 11/2019
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2021 - 07/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 07/2020
2	trioctyl phosphine oxide (TOPO)IBA 01/2021 - 07/2018
2	anti-scl-70 autoantibodiesIBA 07/2018 - 01/2017
2	Crystallins (Crystallin)IBA 02/2012 - 05/2007
2	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 02/2010 - 07/2009
2	LectinsIBA 01/2006 - 12/2002
2	Serotonin (5 Hydroxytryptamine)IBA 11/2003 - 02/2002
1	COVAC-1 COVID-19 vaccineIBA 01/2022
1	Monatide (IMS 3015)IBA 01/2022
1	Toll-Like Receptor 1IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	canakinumab FDA Link 02/2021
1	Colchicine FDA LinkGeneric 02/2021
1	InterleukinsIBA 02/2021
1	Angiotensin IIIBA 01/2021
1	CollagenIBA 01/2021
1	MHC class I-related chain AIBA 01/2021
1	micaIBA 01/2021
1	OligonucleotidesIBA 11/2020
1	defibrotideIBA 11/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	ibrutinibIBA 01/2020
1	EmulsionsIBA 11/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Sulfite OxidaseIBA 05/2018
1	Lenalidomide (CC 5013)FDA Link 01/2018
1	Retinaldehyde (Retinal)IBA 12/2017
1	Cholinergic ReceptorsIBA 09/2013
1	CytokinesIBA 09/2013
1	Immunoglobulins (Immunoglobulin)IBA 01/2013
1	Adalimumab (Humira)FDA Link 01/2013
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2013
1	Rituximab (Mabthera)FDA Link 01/2013
1	Endothelin Receptor AntagonistsIBA 07/2012
1	Endothelin A ReceptorIBA 07/2012

Therapy/Procedure

8	Therapeutics 01/2022 - 12/2002
3	Immunotherapy 01/2019 - 07/2012
2	Hematopoietic Stem Cell Transplantation 07/2020 - 08/2015
2	Stem Cell Transplantation 07/2018 - 01/2017
2	Liver Transplantation 09/2002 - 04/2002
1	Chemoradiotherapy 01/2022
1	Vegan Diet (Diet, Vegan) 11/2020
1	Intravenous Administration 01/2017
1	Off-Label Use 01/2017
1	Aftercare (After-Treatment) 01/2013